Neurotransmitter Systems and Receptors

Neurotransmitter systems are the chemical signalling pathways through which neurons communicate at synapses: a presynaptic cell releases a transmitter that binds receptors on a target cell, changing its electrical or biochemical state. This area surveys the major transmitter families of the central nervous system and the receptor proteins they act on, because these systems are the molecular targets of most psychoactive and neurological drugs.

Definition

A neurotransmitter system comprises a signalling molecule (the transmitter), the enzymes and transporters that synthesise, store, and clear it, and the receptors through which it acts; receptors are broadly either ionotropic (ligand-gated ion channels giving fast signalling) or metabotropic (G-protein-coupled, giving slower, modulatory signalling).

Scope

The area orients the reader to how chemical neurotransmission is organised and why it matters for pharmacology. It groups the field into the monoamines, the principal fast amino-acid transmitters (inhibitory GABA and excitatory glutamate), the endogenous opioid peptide system, and central cholinergic signalling. It treats these systems as reference knowledge underlying neuropsychopharmacology, not as clinical or prescribing guidance.

Sub-topics

• Acetylcholine and Cholinergic Neurotransmission in CNS
• GABA and Inhibitory Neurotransmission
• Glutamate and Excitatory Amino Acid Neurotransmission
• Monoamine Neurotransmission
• Opioid Receptor Systems and Endogenous Opioids

Core questions

• Which transmitter families operate in the CNS and what functional roles do they serve?
• How do ionotropic and metabotropic receptors differ in mechanism and timescale?
• How is a transmitter synthesised, released, and inactivated, and where can drugs intervene?
• Why are neurotransmitter receptors the dominant targets of psychoactive medicines?

Key concepts

• Chemical synaptic transmission
• Ionotropic (ligand-gated) receptors
• Metabotropic (G-protein-coupled) receptors
• Excitatory and inhibitory neurotransmission
• Reuptake transporters and enzymatic degradation
• Receptor agonists, antagonists, and modulators
• Neuromodulation

Mechanisms

Across systems the shared logic is release, recognition, and termination. A transmitter is synthesised, packaged into vesicles, and released into the synaptic cleft, where it binds receptors on the postsynaptic (and sometimes presynaptic) membrane. Ionotropic receptors are themselves ion channels and produce fast excitatory or inhibitory currents, as seen for glutamate and GABA-A receptors; metabotropic receptors couple to G proteins and produce slower, modulatory effects, as for dopamine, muscarinic, and opioid receptors. The signal is terminated by reuptake transporters or by enzymatic breakdown, and these clearance steps are themselves major drug targets. Beaulieu and Gainetdinov (2011), Traynelis et al. (2010), Olsen and Sieghart (2008), and Picciotto et al. (2012) describe representative receptor families spanning these mechanisms.

Clinical relevance

Most drugs used in psychiatry and neurology act by altering neurotransmission, whether by mimicking or blocking a receptor, by inhibiting a reuptake transporter, or by modulating a channel. Understanding these systems is therefore central to interpreting how such agents are thought to work. This area is descriptive reference material on signalling and is not a basis for selecting, dosing, or adjusting any treatment.

Evidence & guidelines

Receptor classification and nomenclature in this area follow consensus syntheses such as the IUPHAR receptor reviews; the cited Pharmacological Reviews articles represent that authoritative review literature for the dopamine, glutamate, and GABA-A systems.

History

Chemical neurotransmission was established in the early twentieth century, and the second half of the century saw the systematic identification of transmitter families and the cloning of their receptors. The recognition that receptors fall into ionotropic and metabotropic classes, and that distinct receptor subtypes mediate different actions, reshaped pharmacology into a receptor-centred discipline and underlies modern neuropsychopharmacology.

Seminal works

• beaulieu-2011
• traynelis-2010
• olsen-sieghart-2008

Frequently asked questions

What is the difference between ionotropic and metabotropic receptors?

An ionotropic receptor is itself an ion channel that opens when the transmitter binds, producing fast signalling; a metabotropic receptor is coupled to a G protein and triggers slower intracellular signalling cascades that modulate the cell.

Why are neurotransmitter systems so important in pharmacology?

Because most psychoactive and neurological drugs work by changing neurotransmission, the transmitters, their receptors, and their clearance pathways are the principal molecular targets through which these medicines are understood to act.